The ascendancy of Viagra and its impact on the drug landscape presents a intricate question for investors. While the early sales statistics were impressive, the patent has lapsed, leading to a flood of generic alternatives that are eroding profit. In addition, the industry is facing issues related to aging trends and evolving healthcare regulati… Read More